Business
Senseonics Announces Partnership with Companion Medical
Eversense long-term CGM and InPen System to integrate sensor glucose and insulin data. GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE
About this update from Senseonics Holdings, Inc.
[{"type":"text","content":"\nEversense long-term CGM and InPen System to integrate sensor glucose and insulin data. \n\n GERMANTOWN, Md.--(BUSINESS WIRE)--\nSenseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system, today announced an agreement with Companion Medical to integrate Eversense® CGM System real-time glucose data with the Companion Medical InPen™ smart system for insulin delivery. For people living with insulin-dependent diabetes, this news means that real-time glucose data will continuously be incorporated into their InPen insulin system allowing for more relevant insulin dosing information which will inform improved diabetes management decisions.\n\n\n“There is a strong desire from people living with diabetes to have a complete picture of their real-time glucose values, rate of change and insulin information in one place so they can make better diabetes management decisions,” said Tim Goodnow, PhD, President and CEO of Senseonics. “By partnering with Companion Medical, multiple daily injection patients using the InPen System will be able to take full advantage of the convenience of insightful and comprehensive insulin data integrated with their Eversense CGM data, giving them a more complete picture and meaningful information at their fingertips.”\n\n\n“CGM has revolutionized glucose monitoring and InPen has revolutionized MDI therapy. Together this is going to be a new world for those of us who manage our diabetes with MDI. Combining these technologies is a real game-changer,” said Companion’s Chief Executive Officer Sean Saint. “At Companion Medical our mission is to create affordable, easy-to-use solutions that allow people with insulin-dependent diabetes to focus more on their lives and less on their condition and the team at Senseonics is a great partner with a similar vision. We are excited about what our partnership with Senseonics will bring to those living with diabetes, their healthcare teams, payers and the smart pen category overall.”\n\n\nThe Eversense CGM System consists of a fluorescence-based sensor, a smart transmitter worn over the sensor to facilitate data communication, and a mobile app for displaying glucose values, trends and alerts. In addition to featuring the first...